Hepatitis C Virus Core Protein Induces Homotolerance and Cross-Tolerance to Toll-Like Receptor Ligands by Activation of Toll-Like Receptor 2

被引:45
|
作者
Chung, Hobyung [2 ]
Watanabe, Tomohiro [1 ]
Kudo, Masatoshi [2 ]
Chiba, Tsutomu
机构
[1] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan
[2] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 589, Japan
来源
JOURNAL OF INFECTIOUS DISEASES | 2010年 / 202卷 / 06期
关键词
NEGATIVE REGULATOR; IMMUNE-RESPONSES; ADAPTER PROTEIN; DENDRITIC CELLS; INFECTION; INDUCTION; LIVER; ANTIGEN; INTERLEUKIN-6; ASSOCIATION;
D O I
10.1086/655812
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Hepatitis C virus (HCV) activates host innate immune responses mediated by retinoic acid inducing gene-I (RIG-I) and Toll-like receptors (TLRs). Although the nonstructural protein 3/4A (NS3/4A) of HCV disrupts interferon responses by inhibiting RIG-I signaling, the effects of TLR activation by HCV-associated proteins on host innate immune responses are poorly understood. Methods. Proinflammatory cytokine responses to various TLR ligands in human antigen-presenting cells (APCs) were examined either with or without prestimulation by HCV core protein. Results. TLR2 activation by the HCV core protein leads to a decrease in interleukin 6 (IL-6) production by human APCs after subsequent stimulation with TLR2 (homotolerance) ligands and TLR4 (cross-tolerance) ligands. This hyporesponsiveness induced by preexposure to the HCV core protein was partially mediated by the negative regulation of nuclear factor-kappa B activation by the induction of IRAK-M. TLR ligand-induced IL-6 production was significantly reduced in peripheral blood monocytes isolated from HCV-infected patients, compared with those of healthy control subjects. Alloantigen presentation by monocytes isolated from HCV-infected patients results in impaired production of interleukin 17 by naive CD4(+) T cells in the presence of TLR ligands. Conclusions. Chronic stimulation of APCs with HCV core protein is associated with hyporesponsiveness in TLR-mediated innate immunity.
引用
收藏
页码:853 / 861
页数:9
相关论文
共 50 条
  • [11] Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides
    Tapping, RI
    Akashi, S
    Miyake, K
    Godowski, PJ
    Tobias, PS
    JOURNAL OF IMMUNOLOGY, 2000, 165 (10): : 5780 - 5787
  • [12] Evaluation of Lipopeptides as Toll-like Receptor 2 Ligands
    Hussein, Waleed M.
    Choi, Phil M.
    Zhang, Cheng
    Su, Mei
    Sierecki, Emma
    Johnston, Wayne
    Fagan, Vincent
    Alexandrov, Kirill
    Skwarczynski, Mariusz
    Gambin, Yann
    Toth, Istvan
    Simerska, Pavla
    CURRENT DRUG DELIVERY, 2017, 14 (07) : 935 - 943
  • [13] Simple synthetic toll-like receptor 2 ligands
    Abdel-Aal, Abu-Baker M.
    Al-Isae, Kalifa
    Zaman, Mehfuz
    Toth, Istvan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (19) : 5863 - 5865
  • [14] Distribution of Toll-like receptor 1 and Toll-like receptor 2 in human lymphoid tissue
    Ochoa, MT
    Legaspi, AJ
    Hatziris, Z
    Godowski, PJ
    Modlin, RL
    Sieling, PA
    IMMUNOLOGY, 2003, 108 (01) : 10 - 15
  • [15] Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease
    Moens, Leen
    Verhaegen, Jan
    Pierik, Marie
    Vermeire, Severine
    De Boeck, Kris
    Peetermans, Willy E.
    Bossuyt, Xavier
    MICROBES AND INFECTION, 2007, 9 (01) : 15 - 20
  • [16] Expression of Toll-like Receptor 2 and Toll-like Receptor 4 in Tuberculous Pleural Effusion
    Lin, Yingzhong
    Feng, Tingmei
    Lan, Jiao
    Chen, Chunxia
    Qin, Zhiqiang
    Wu, Yanbin
    Shi, Huanzhong
    Ye, Jianbo
    Wei, Caizhou
    Wang, Wu
    Huang, Luying
    MEDICINAL CHEMISTRY, 2017, 13 (06) : 569 - 576
  • [17] Stimulation of autoimmunity by toll-like receptor ligands
    Limmer, A
    Ganss, R
    Garbi, N
    Arnold, B
    Hämmerling, GJ
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 15 - 17
  • [18] Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood
    De Wit, D
    Tonon, S
    Olislagers, V
    Goriely, S
    Boutriaux, M
    Goldman, M
    Willems, F
    JOURNAL OF AUTOIMMUNITY, 2003, 21 (03) : 277 - 281
  • [19] Vaccines Incorporating Toll-Like Receptor Ligands
    Shaw, Alan
    BIOPHARM INTERNATIONAL, 2008, : 24 - +
  • [20] Toll-like receptor activation in immunity vs. tolerance
    Filippi, Christophe M.
    FRONTIERS IN IMMUNOLOGY, 2015, 6